Medindia

X

Corgenix Reports Third Quarter Fiscal 2010 Financial Results

Thursday, May 13, 2010 General News J E 4
Advertisement
-- Sales increase 8.1% vs. prior year and Company achieves net income for the quarter vs. substantial loss in prior year --

SUMMARY BALANCE SHEET DATA

(in thousands)

March 31, 2010

(unaudited)

June 30, 2009

(audited)

Cash

$      488

$    785

Working capital

2,091

2,013

Total assets

6,446

6,906

Long-term debt

547

744

Total stockholders' equity

3,105

3,113

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Vista Partners Updates Coverage on Pro-Pharmaceuti...
S
Novavax Announces Publication of a Pre-clinical St...